Literature DB >> 26824458

Pttg1 Promotes Growth of Breast Cancer through P27 Nuclear Exclusion.

Yishan Xiea1, Rui Wangb.   

Abstract

BACKGROUND/AIMS: A role of Pituitary Tumor Transforming Gene 1 (Pttg1) in the carcinogenesis has been shown in some cancers, but not in BC (BC).
METHODS: We compared the levels of Pttg1 in the resected BC tissue with the adjacent normal breast tissue from the same patient. We modified Pttg1 levels in a BC cell line, MCF7, by either a Pttg1 transgene, or a Pttg1 shRNA. The cell growth was measured in an MTT assay. The cell apoptosis was measured by apoptosis assay. The nuclear protein of cell-cycle-related genes was examined in Pttg1-modifed BC cells. Co-immunoprecipitation was performed to examine the association of Pttg1 and p27.
RESULTS: We detected significantly higher levels of Pttg1 in the resected BC tissue, compared to the adjacent normal breast tissue from the same patient. Overexpression or depletion of Pttg1 in MCF7 significantly increased or inhibited cell growth, respectively. Changes in Pttg1 levels, however, did not alter cell apoptosis, suggesting that Pttg1 increases cell growth through augmented cell proliferation, rather than decreased cell apoptosis. Among all examined cell-cycle-related proteins in Pttg1-modifed BC cells, only nuclear p27 levels were significantly affected. Further, co-immunoprecipitation showed that Pttg1 directly associated with p27.
CONCLUSION: Pttg1 may increase BC cell growth through nuclear exclusion of p27, which highlights a novel molecular regulatory machinery in tumorigenesis of BC.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26824458     DOI: 10.1159/000438660

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

1.  Simvastatin Suppresses Human Breast Cancer Cell Invasion by Decreasing the Expression of Pituitary Tumor-Transforming Gene 1.

Authors:  Litian Yin; Zhongmei He; Bing Yi; Linyuan Xue; Jianxin Sun
Journal:  Front Pharmacol       Date:  2020-11-04       Impact factor: 5.810

2.  A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.

Authors:  Xiongtao Yang; Guohui Wang; Runchuan Gu; Xiaohong Xu; Guangying Zhu
Journal:  PeerJ       Date:  2020-11-26       Impact factor: 2.984

3.  Integrated bioinformatics analysis to identify 15 hub genes in breast cancer.

Authors:  Haoxuan Jin; Xiaoyan Huang; Kang Shao; Guibo Li; Jian Wang; Huanming Yang; Yong Hou
Journal:  Oncol Lett       Date:  2019-05-30       Impact factor: 2.967

4.  Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.

Authors:  Lina Qi; Biting Zhou; Jiani Chen; Wangxiong Hu; Rui Bai; Chenyang Ye; Xingyue Weng; Shu Zheng
Journal:  J Cancer       Date:  2019-10-21       Impact factor: 4.207

5.  Risk Stratification for Breast Cancer Patient by Simultaneous Learning of Molecular Subtype and Survival Outcome Using Genetic Algorithm-Based Gene Set Selection.

Authors:  Bonil Koo; Dohoon Lee; Sangseon Lee; Inyoung Sung; Sun Kim; Sunho Lee
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

6.  Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset.

Authors:  Xiang Liu; Wei Zeng; Dayang Zheng; Min Tang; Wangyan Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

7.  Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.

Authors:  JinHui Liu; YiCong Wan; Siyue Li; HuaiDe Qiu; Yi Jiang; Xiaoling Ma; ShuLin Zhou; WenJun Cheng
Journal:  Cancer Med       Date:  2020-03-14       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.